本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

19.20
-0.3100-1.59%
盤後19.16-0.0400-0.21%19:50 EDT
成交量:209.98萬
成交額:4,006.65萬
市值:54.17億
市盈率:-5.97
高:19.40
開:19.40
低:18.60
收:19.51
52周最高:42.50
52周最低:16.28
股本:2.82億
流通股本:9,191.75萬
量比:1.23
換手率:2.28%
股息:- -
股息率:- -
每股收益(TTM):-3.2173
每股收益(LYR):-3.2200
淨資產收益率:-45.37%
總資產收益率:3.84%
市淨率:9.38
市盈率(LYR):-5.96

資料載入中...

2021/06/08

重要事件披露

8-K - Current report
2021/05/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/29

重要事件披露

8-K - Current report
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/31

重要事件披露

8-K - Current report
2020/12/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/06

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]